D16 - An Ounce of Prevention: Treatment Options to Prevent Progression of Prediabetes to T2D

Sunday, August 10, 2025

1:30 PM - 2:15 PM MST

CE/CME Hours: .75 CE

Pharmacology Hours: .25 CE

The ADA Standards of Care 2025 stress the importance of screening for pre-diabetes in high-risk adults to delay the onset of T2D and complications. Intensive lifestyle behavior change is the first-line for prevention and includes weight loss, exercise, and reduced calorie intake. Randomized clinical trials provide evidence that a reduced-calorie meal plan is effective in delaying T2D and improving cardiometabolic risk factors. Clinical evidence has shown that weight-loss medications and technologies, including CGM, are effective in preventing progression to T2D in patients with pre-diabetes. This session reviews current evidence for treatment options to delay progression of pre-diabetes and how to implement screening and treatment into clinical practice.

Disclosure(s):

Kimberly Barefield, PharmD: No financial relationships to disclose

Idopise Umana, MD, FACP: No financial relationships to disclose

Primary Presenter(s)

Kimberly L. Barefield, PharmD (she/her/hers)

Associate Professor
PCOM School of Pharmacy
Flowery Branch, Georgia

Disclosure(s): No financial relationships to disclose

Co-Presenter(s)

Nawras Silin, MD

Fellow in training
Detroit Medical Center
Sterling Heights, Michigan

Disclosure information not submitted.

Session Host(s)

Sneha Srivastava, PharmD, BCACP, DIPACLM, CDCES, FADCES (she/her/hers)

Associate Director of Skills Education and Clinical Pharmacist
Rosalind Franklin University of Medicine and Scien
North Chicago, Illinois

Disclosure information not submitted.